ADT
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ADT
Jun 9, 2024, 12:59 |
Insight
Andy Hahn: Check out our editorial on CV risk in men with prostate cancer treated with ADT
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X: “Check out…
May 9, 2024, 06:45 |
Insight
Piotr Wysocki: Neoadjuvant chemo-hormonal therapy before prostatectomy: First randomized study
Piotr Wysocki recently posted on LinkedIn: "Qian H et al. conducted a randomized clinical trial (phase…
May 8, 2024, 02:11 |
Blog
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "RADIOSA trial: oligorecurrent…
May 6, 2024, 19:27 |
Blog
Yüksel Ürün: Critical intersections on androgen deprivation therapy (ADT) in prostate cancer treatment and cardiovascular health
Yüksel Ürün shared on Twitter/X: "Critical intersections between androgen deprivation therapy (ADT) in prostate cancer…
Aug 25, 2023, 18:22 |
Insight
Earle Burgess: Which newly diagnosed metastatic castrate-sensitive prostate cancer patients need to add docetaxel chemotherapy to an ADT + ARPI doublet?
Quoting Earle Burgess, Genitourinary Medical Oncologist and Clinical Researcher at Atrium Health, Levine Cancer Institute,…
All:
5
Posts:
1 - 10
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Facebook
RSS Feed
Twitter
Linkedin
Youtube